Market Cap (In AUD)
32.27 Million
Revenue (In AUD)
3.09 Million
Net Income (In AUD)
-6.4 Million
Avg. Volume
425.64 Thousand
- Currency
- AUD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.085-0.185
- PE
- -
- EPS
- -
- Beta Value
- 0.744
- ISIN
- AU0000160921
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Mr. Shane Ryan M.B.A.
- Employee Count
- -
- Website
- https://www.bcaldiagnostics.com
- Ipo Date
- 2021-07-21
- Details
- BCAL Diagnostics Limited, a biotechnology company, engages in developing a non-invasive laboratory blood test for the detection of breast cancer. It develops BCAL test, a lipid biomarker blood test with the potential to be used for breast cancer prevention, screening, and monitoring; and in vitro diagnostic test (IVD) that confirms a fingerprint of lipid biomarkers extracted from extracellular vesicles from a patient's plasma or blood sample to diagnose the presence of breast cancer cells in a patient's body. The company was incorporated in 2010 and is headquartered in Sydney, Australia.
More Stocks
-
LLOBF
-
SOTS
-
CFR
-
MBK
-
GMEGameStop Corp.
GME
-
MVES
-
BHP
-
0VHI